Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the pharmacokinetics of XR quetiapine
fumarate(300mg,600mg,and 800mg once-daily) in Chinese schizophrenic patients .